Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) traded up 1.7% on Tuesday . The stock traded as high as $1.20 and last traded at $1.19. 10,036 shares were traded during trading, a decline of 44% from the average session volume of 17,766 shares. The stock had previously closed at $1.17. Medexus Pharmaceuticals […]
Medexus Pharmaceuticals Inc.: Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Medexus Pharmaceuticals is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024.Event: 2024 Bloom...
Medexus Pharmaceuticals Inc.: Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Medexus Pharmaceuticals today announced that the US Food and Drug Administration recently approved Medexus's supplemental Biologics License Application for IXINITY® [coagulation factor IX ] for...